ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Use of Dovato in Virologically Suppressed Adults with HIV-1 Read more
Mesoblast and Lonza Enter into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Therapy Read more
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Galapagos NV Read more
Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells Read more
CRISPR And KSQ Therapeutics Announce License Agreement To Advance Companies’ Respective Cell Therapy Programs In Oncology Read more